State Street’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $91.4M | Buy |
|
|||||
|
2025
Q2 | $61.7M | Sell |
|
|||||
|
2025
Q1 | $86.2M | Sell |
|
|||||
|
2024
Q4 | $144M | Buy |
|
|||||
|
2024
Q3 | $117M | Sell |
|
|||||
|
2024
Q2 | $159M | Buy |
|
|||||
|
2024
Q1 | $171M | Sell |
|
|||||
|
2023
Q4 | $175M | Sell |
|
|||||
|
2023
Q3 | $123M | Buy |
|
|||||
|
2023
Q2 | $208M | Sell |
|
|||||
|
2023
Q1 | $197M | Sell |
|
|||||
|
2022
Q4 | $180M | Buy |
|
|||||
|
2022
Q3 | $202M | Sell |
|
|||||
|
2022
Q2 | $158M | Buy |
|
|||||
|
2022
Q1 | $148M | Buy |
|
|||||
|
2021
Q4 | $129M | Sell |
|
|||||
|
2021
Q3 | $93.2M | Buy |
|
|||||
|
2021
Q2 | $123M | Sell |
|
|||||
|
2021
Q1 | $94.3M | Sell |
|
|||||
|
2020
Q4 | $139M | Sell |
|
|||||
|
2020
Q3 | $86.4M | Sell |
|
|||||
|
2020
Q2 | $96.2M | Buy |
|
|||||
|
2020
Q1 | $66.9M | Buy |
|
|||||
|
2019
Q4 | $70.4M | Buy |
|
|||||
|
2019
Q3 | $37.4M | Sell |
|
|||||
|
2019
Q2 | $43M | Buy |
|
|||||
|
2019
Q1 | $20.9M | Buy |
|
|||||
|
2018
Q4 | $14M | Sell |
|
|||||
|
2018
Q3 | $24.3M | Buy |
|
|||||
|
2018
Q2 | $26.6M | Buy |
|
|||||
|
2018
Q1 | $3.78M | Buy |
|
|||||
|
2017
Q4 | $2.08M | Buy |
|